The blood-testing device producer, which counts Access Industries and Haisco as investors, has added $28m to its coffers.

Sight Diagnostics, an Israel-based medical diagnostics device developer backed by conglomerate Access Industries, has secured $28m from unnamed investors, Globes has reported, citing news from Access subsidiary Clal Biotechnology Industries. Although the investors were not disclosed, announcement stated that Anatomy, a fund 50% held by Clal Biotechnology, will own a 7% stake in Sight once…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.